Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR35 | Q9HC97 | 5/20 | 0.50 |
| ▸ | TSHR | P16473 | 2/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.49 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.49 |
| ▸ | HPGD | P15428 | 1/20 | 0.49 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.49 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.49 |
| ▸ | TXNRD1 | Q16881 | 1/20 | 0.49 |
| ▸ | TXNRD3 | Q86VQ6 | 1/20 | 0.49 |
| ▸ | TXNRD2 | Q9NNW7 | 1/20 | 0.49 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.49 |
| ▸ | KIF11 | P52732 | 5/20 | 0.44 |
| ▸ | EPAS1 | Q99814 | 2/20 | 0.42 |
| ▸ | VEGFA | P15692 | 1/20 | 0.41 |
| ▸ | TTR | P02766 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29659699 | 0.85 | TSHR (0.58) | GPR35TSHRALDH1A1CYP3A4HPGD | |
| SCHEMBL2054426 | 0.85 | TSHR (0.58) | GPR35TSHRALDH1A1CYP3A4HPGD | |
| SCHEMBL10063513 | 0.81 | ALDH1A1 (0.49) | GPR35TSHRALDH1A1CYP3A4HPGD | |
| SCHEMBL1018978 | 0.81 | GPR35 (0.49) | GPR35TSHRALDH1A1CYP3A4HPGD | |
| SCHEMBL31474764 | 0.79 | GPR35 (0.71) | GPR35TSHRALDH1A1CYP3A4HPGD | |
| SCHEMBL11285928 | 0.79 | GPR35 (0.71) | GPR35TSHRALDH1A1CYP3A4HPGD | |
| SCHEMBL30469434 | 0.79 | TSHR (0.54) | GPR35TSHRALDH1A1CYP3A4HPGD | |
| SCHEMBL11398704 | 0.77 | ALDH1A1 (0.45) | TSHRALDH1A1CYP3A4HPGDALOX15 | |
| SCHEMBL11082077 | 0.77 | KIF11 (0.52) | TSHRALDH1A1CYP3A4HPGDALOX15 | |
| SCHEMBL11385032 | 0.77 | TSHR (0.45) | TSHRALDH1A1CYP3A4HPGDALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119264043-A | High-quality fluazinam high-efficiency synthesis process | 吴忠领航生物药业科技有限公司 | 2025-01-07 | — | — | CN | disclosed |
| CN-108929264-A | A kind of preparation method of fluazinam | 岳晟 | 2018-12-04 | — | — | CN | disclosed |
| US-8648203-B2 | Process for preparing pyridinamines and novel polymorphs thereof | MAKHTESHIM CHEMICAL WORKS LTD. (IL) | 2014-02-11 | — | — | US | disclosed |
| US-8648203-B2 | Process for preparing pyridinamines and novel polymorphs thereof | MAKHTESHIM CHEMICAL WORKS LTD. (IL) | 2014-02-11 | — | — | US | disclosed |
| US-20120197023-A1 | PROCESS FOR PREPARING PYRIDINAMINES AND NOVEL POLYMORPHS THEREOF | MAKHTESHIM CHEMICAL WORKS LTD. (IL) | 2012-08-02 | — | — | US | disclosed |
| US-20120197023-A1 | PROCESS FOR PREPARING PYRIDINAMINES AND NOVEL POLYMORPHS THEREOF | MAKHTESHIM CHEMICAL WORKS LTD. (IL) | 2012-08-02 | — | — | US | disclosed |
| US-8163930-B2 | Process for preparing pyridinamines and novel polymorphs thereof | MAKHTESHIM CHEMICAL WORKS LTD. (IL) | 2012-04-24 | — | — | US | disclosed |
| US-8163930-B2 | Process for preparing pyridinamines and novel polymorphs thereof | MAKHTESHIM CHEMICAL WORKS LTD. (IL) | 2012-04-24 | — | — | US | disclosed |
| US-20090075823-A1 | PROCESS FOR PREPARING PYRIDINAMINES AND NOVEL POLYMORPHS THEREOF | MAKHTESHIM CHEMICAL WORKS LTD. (IL) | 2009-03-19 | — | — | US | disclosed |
| US-20090075823-A1 | PROCESS FOR PREPARING PYRIDINAMINES AND NOVEL POLYMORPHS THEREOF | MAKHTESHIM CHEMICAL WORKS LTD. (IL) | 2009-03-19 | — | — | US | disclosed |
| WO-2007060662-A2 | PROCESS FOR PREPARING PYRIDINAMINES AND NOVEL POLYMORPHS THEREOF | MAKHTESHIM CHEMICAL WORKS LTD. (IL) | 2007-05-31 | — | — | WO | disclosed |
| EP-0256504-B1 | PROCESS FOR THE EXTRACTION OF NITRO-HYDROXY-AROMATES FROM AQUEOUS SOLUTIONS | HOECHST AKTIENGESELLSCHAFT (DE) | 1990-12-27 | — | — | EP | disclosed |
| US-4814518-A | SOLVENT EXTRACTION, AMINE SALTS | HOECHST AKTIENGESELLSCHAFT (DE) | 1989-03-21 | — | — | US | disclosed |
| EP-0256504-A1 | Process for the extraction of nitro-hydroxy-aromates from aqueous solutions | HOECHST AKTIENGESELLSCHAFT (DE) | 1988-02-24 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120197023-A1 | PROCESS FOR PREPARING PYRIDINAMINES AND NOVEL POLYMORPHS THEREOF | PDXK, FN3KRP, PTMS | GPR35 3730/4885TSHR 1868/4885ALDH1A1 2742/4885 |
| US-20090075823-A1 | PROCESS FOR PREPARING PYRIDINAMINES AND NOVEL POLYMORPHS THEREOF | PDXK, IPMK, DMPK | GPR35 3157/4885TSHR 1785/4885ALDH1A1 2439/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.